diabetes-juvenil-glp1-en.md

---

title: "GLP-1 for Children and Adolescents with Type 2 Diabetes" metaTitle: "GLP-1 for Children and Adolescents with Type 2 Diabetes" metaDescription: "Learn how GLP-1 medications work in children and adolescents with type 2 diabetes, which ones are approved, and when to consider this option." siteId: ozempro categoryId: cf239058-fe52-41a7-8a6b-dbb7b5934eb4 status: SCHEDULED publishedAt: 2026-07-01T09:00:00.000Z

---

Your 13-year-old just got diagnosed with type 2 diabetes. You weren't expecting this. The first thought that comes to mind is: what now?

First, take a breath. You are not alone in this, and treatment options have come a long way in recent years. One of them involves GLP-1 medications, which are changing the way doctors and families manage type 2 diabetes in young people. This guide walks you through what you need to know, with real data and no unnecessary alarm.

Type 2 Diabetes in Children: More Common Than You Think

There is a belief that type 2 diabetes is an adult condition. It is not. More and more children and teenagers are receiving this diagnosis worldwide. In Brazil, the Brazilian Diabetes Society has reported a significant increase in cases among young people over the past two decades.

This trend is linked to childhood obesity, sedentary lifestyles, and family history. These risk factors often appear together, even when nothing could have been done differently to prevent them.

To understand the difference between the types: in type 1 diabetes, the body stops producing insulin. In type 2, which is the most common in young people, the problem is insulin resistance. The body makes the hormone, but the cells do not respond well to it. Sugar stays in the bloodstream instead of entering where it should.

Traditional treatment includes metformin and, when needed, insulin. The problem is that these do not always work well over time. The TODAY study, which followed young people ages 10 to 17 in the United States, found that metformin alone stopped controlling blood sugar in roughly half of patients within just three years. That data is not meant to scare you. It is meant to show that having other options available is a real advantage.

The International Diabetes Federation estimates that approximately 1.5 million children and adolescents live with type 2 diabetes worldwide. That is a large community, with active research and constantly evolving treatments.

What GLP-1 Is and Why It Works Differently

GLP-1 stands for glucagon-like peptide-1, an intestinal hormone that the body naturally produces after eating. In people with type 2 diabetes, this hormone is present in insufficient amounts. A GLP-1 medication synthetically replaces that function.

The mechanism is different from other diabetes drugs. GLP-1 lowers blood sugar after meals by stimulating insulin release exactly when the body needs it. Another important action is the slowing of gastric emptying, which keeps you feeling full longer. There is also direct activity on the appetite center in the brain, which reduces hunger naturally.

For children and adolescents who are overweight, this is particularly relevant. This is not about making a child eat less through sheer willpower. The medication helps regulate what the body feels, making the process simpler for everyone.

Clinical data backs up what doctors already see in practice. In studies with liraglutide and semaglutide, adolescents showed HbA1c reductions between 0.5% and 2.0%, depending on dose and follow-up. The ASSERT trial, which specifically studied semaglutide in young people, showed an average weight loss of 2.5 kilograms over 68 weeks, alongside improved blood sugar control.

Which GLP-1 Medications Are Approved for Pediatric Use

There are concrete options available. Liraglutide, known by the brand names Victoza and Saxenda, is approved by ANVISA for adolescents ages 10 to 17 with type 2 diabetes. It is injected subcutaneously once daily, with a maximum dose of 1.8 milligrams per day.

Injectable semaglutide, sold as Ozempic, was approved by the FDA in the United States for adolescents 12 and older. The weekly injection fits more easily into a daily routine. In Brazil, the medication is still under review by ANVISA, but doctors do prescribe it off-label with specialized monitoring.

Oral semaglutide, marketed as Rybelsus, has more limited pediatric data and is still under investigation.

Any GLP-1 medication for a child or adolescent requires a prescription and follow-up with a pediatric endocrinologist. Never start treatment on your own. Cost is still a significant barrier in Brazil. Health insurance plans do not always cover these medications, and the monthly price can be high. Talk openly with your doctor about this.

Real Benefits: What the Studies Show

The results are encouraging without exaggeration. In the ASSERT trial, which tested semaglutide in adolescents, 73% of participants reached HbA1c below 7% compared to only 25% in the placebo group. That difference is meaningful.

Weight loss happens gradually and is clinically significant. In the same study, the average was 2.5 kilograms over 68 weeks, compared with 0.9 kilogram in the placebo group. This is not a quick transformation, but it is a result that impacts metabolic health.

With liraglutide, the NEJNI study showed that 56% of young people reached HbA1c below 7% compared with 32% in the placebo group. The average HbA1c reduction was 0.64% after 26 weeks.

Beyond the numbers, there are reports of improved quality of life. Many young people say they feel less excessive hunger, more energy, and less of that brain fog that high blood sugar causes. The injection routine, whether daily or weekly, tends to be simpler than multiple insulin doses.

Side Effects: What to Watch For

Every medication has possible effects. Being honest about them is the best way for your family to be prepared.

Gastrointestinal symptoms are the most common. Nausea, vomiting, and diarrhea occur especially at the start of treatment, when the body is still adjusting. In most cases, they are mild and improve within a few weeks.

Low blood sugar is rare when GLP-1 is used without insulin or sulfonylureas. Even so, it is important to know the warning signs: trembling, cold sweats, mental confusion. If any of these show up, let your doctor know.

Pancreatitis is extremely rare, but you should tell your doctor right away if your child complains of intense, persistent abdominal pain.

Injection site reactions, such as mild redness or swelling, can occur. Generally, they are temporary.

The key point is this: never stop treatment on your own. If any new symptom shows up, the first step is to contact your doctor. That applies to any medication, not just GLP-1. Regular follow-up is what keeps everyone safe.

What Holistic Care Looks Like: Beyond the Medication

GLP-1 is a powerful tool, but it is not the entire treatment. Proper management of type 2 diabetes in young people involves a pediatric endocrinologist, a nutritionist, a physical activity specialist, and, when needed, psychological support.

With food, the goal is not to restrict meals to the point of turning eating into a battlefield. The focus is on regular meals, fewer ultra-processed foods, and more fiber and protein. When the whole family adopts these habits, it becomes much easier for the teenager to keep up.

For physical activity, the recommendation is at least 60 minutes of moderate movement per day. It does not have to be the gym or competitive sports. Walking, cycling, outdoor play, dancing. Anything that involves movement counts.

The emotional side deserves special attention. Receiving a diagnosis of a chronic disease is hard for anyone, even more so for a child or teenager. Anxiety, sadness, and resistance to treatment are normal responses. Seeking psychological support is not weakness. It is part of the care.

The factor that most impacts treatment adherence is family support. When parents and caregivers are actively involved, the teenager feels backed up and not alone in their care routine.

When GLP-1 Is an Option and How to Start the Conversation with Your Doctor

GLP-1 usually comes into play when metformin alone is not enough to control blood sugar, or when overweight and obesity are affecting metabolic health. It is not the first line of treatment, but it is a next step with strong clinical evidence.

Practical criteria generally include adolescents age 10 or older with type 2 diabetes, HbA1c between 6.5% and 10%, with or without prior metformin use. The decision depends on the individual case and should be made together with a pediatric endocrinologist.

At the appointment, some questions can help guide the conversation. What is my child's current HbA1c? What treatment options are available? Is there insurance coverage? What will the follow-up schedule look like?

A common concern worth addressing: a doctor who prescribes GLP-1 for a teenager is not experimenting. They are using an option backed by solid, growing clinical evidence and approvals in several countries.

Managing a chronic condition in a child means tracking a lot of moving pieces, from blood sugar readings to medication schedules. The Ozempro app can help keep everything organized in one place, making it easier to share updates with the whole care team and giving parents a clearer picture of how things are going day to day.

For many families, having a dedicated tool like Ozempro makes the daily management feel less overwhelming. You can check whether it fits your routine by taking the quiz.

There is a path forward. With information, support, and the right medical guidance, your child can live a full and well-controlled life.